Increased HRD score in cisplatin resistant penile cancer cells

BACKGROUND/INTRODUCTION: Penile cancer is a rare disease in demand for new therapeutic options. Frequently used combination chemotherapy with 5 fluorouracil (5-FU) and cisplatin (CDDP) in patients with metastatic penile cancer mostly results in the development of acquired drug resistance. Availabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkelmann, Ria, Bankov, Katrin, Döring, Claudia, Cinatl, Jaroslav, Grothe, Sebastian, Rothweiler, Florian, Michaelis, Martin, Schmitt, Christina, Wild, Peter J., Demes, Melanie, Cinatl, Jindrich, Vallo, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789628/
https://www.ncbi.nlm.nih.gov/pubmed/36564761
http://dx.doi.org/10.1186/s12885-022-10432-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789628/
https://www.ncbi.nlm.nih.gov/pubmed/36564761
http://dx.doi.org/10.1186/s12885-022-10432-7

Ejemplares similares